Kymera | Investor Presentation Deck | 41 slides · page 28 of 41
Data from a clinical study of KT-333, showing biomarker response across different dose levels (DL1, DL2, DL3).
Pitch deck · traction · show_traction · dense density
Slide locked Sign in to view
Slide schematic 6/6
chart 4/4 list 1/1 title 1/1
Components 6
bar-grouped bar-grouped line scatter bullet headline
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 0
∅
No frameworks
No framework match is anchored to this slide.